# Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)

> **NCT07441200** · PHASE2 · NOT_YET_RECRUITING · sponsor: **NS Pharma, Inc.** · enrollment: 135 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** NS-863 Low Dose
- **DRUG:** NS-863 High Dose
- **DRUG:** NS-863 Placebo

## Key facts

- **NCT ID:** NCT07441200
- **Lead sponsor:** NS Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-08-01
- **Final completion:** 2028-11-01
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07441200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07441200, "Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07441200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*